
    
      Multicenter, randomized, controlled, single-blinded, three parallel arms study. Group A:
      Atorvastatin + Probucol-placebo + Cilostazol-placebo Group B: Atorvastatin + Probucol +
      Cilostazol-placebo Group C: Atorvastatin + Probucol + Cilostazol
    
  